Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enke Baldini

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Frontiers in Oncology|October 10, 2022
Thyroid and renal cancers: A bidirectional associationMaria Irene Bellini, Eleonora Lori, Flavio Forte, et al.
Frontiers in Endocrinology|January 9, 2019
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle AspirationSilvia Martina Ferrari, Concettina La Motta, Giusy Elia, et al.
International Journal of Endocrinology|August 21, 2018
CTLA-4 and PD-1 Ligand Gene Expression in Epithelial Thyroid CancersChiara Tuccilli, Enke Baldini, Salvatore Sorrenti, et al.
Journal of Personalized Medicine|February 25, 2022
Thyroid Diseases and Breast CancerEnke Baldini, Augusto Lauro, Domenico Tripodi, et al.
Cancers|November 13, 2021
Papillary Thyroid Cancer Prognosis: An Evolving FieldSalvatore Ulisse, Enke Baldini, Augusto Lauro, et al.
International Journal of Molecular Sciences|September 9, 2022
Is Melanoma Progression Affected by Thyroid Diseases?Salvatore Ulisse, Enke Baldini, Daniele Pironi, et al.
Journal of Clinical Medicine|October 14, 2023
Thyroid Autoimmunity and SARS-CoV-2 InfectionPoupak Fallahi, Giusy Elia, Francesca Ragusa, et al.
International Journal of Molecular Sciences|March 23, 2019
PD-1 Ligand Expression in Epithelial Thyroid Cancers: Potential Clinical ImplicationsSalvatore Ulisse, Chiara Tuccilli, Salvatore Sorrenti, et al.
Clinical Endocrinology|June 19, 2012
In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free intervalSalvatore Ulisse, Enke Baldini, Salvatore Sorrenti, et al.
Frontiers in Endocrinology|April 26, 2024
Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactoseSilvia Martina Ferrari, Armando Patrizio, Valeria Mazzi, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Frontiers in Oncology|October 10, 2022
Thyroid and renal cancers: A bidirectional associationMaria Irene Bellini, Eleonora Lori, Flavio Forte, et al.
Frontiers in Endocrinology|January 9, 2019
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle AspirationSilvia Martina Ferrari, Concettina La Motta, Giusy Elia, et al.
International Journal of Endocrinology|August 21, 2018
CTLA-4 and PD-1 Ligand Gene Expression in Epithelial Thyroid CancersChiara Tuccilli, Enke Baldini, Salvatore Sorrenti, et al.
Journal of Personalized Medicine|February 25, 2022
Thyroid Diseases and Breast CancerEnke Baldini, Augusto Lauro, Domenico Tripodi, et al.
Cancers|November 13, 2021
Papillary Thyroid Cancer Prognosis: An Evolving FieldSalvatore Ulisse, Enke Baldini, Augusto Lauro, et al.
International Journal of Molecular Sciences|September 9, 2022
Is Melanoma Progression Affected by Thyroid Diseases?Salvatore Ulisse, Enke Baldini, Daniele Pironi, et al.
Journal of Clinical Medicine|October 14, 2023
Thyroid Autoimmunity and SARS-CoV-2 InfectionPoupak Fallahi, Giusy Elia, Francesca Ragusa, et al.
International Journal of Molecular Sciences|March 23, 2019
PD-1 Ligand Expression in Epithelial Thyroid Cancers: Potential Clinical ImplicationsSalvatore Ulisse, Chiara Tuccilli, Salvatore Sorrenti, et al.
Clinical Endocrinology|June 19, 2012
In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free intervalSalvatore Ulisse, Enke Baldini, Salvatore Sorrenti, et al.
Frontiers in Endocrinology|April 26, 2024
Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactoseSilvia Martina Ferrari, Armando Patrizio, Valeria Mazzi, et al.
Pageof 8